Soligenix, Inc. (SNGX) vs Sonoma Pharmaceuticals, Inc. (SNOA)
A side-by-side comparison of Soligenix, Inc. and Sonoma Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
SNGX
Soligenix, Inc.
$0.36HealthcareDelayed quote: Oct 6, 2026, 3:02 PM EDT
SNOA
Sonoma Pharmaceuticals, Inc.
$1.21HealthcareDelayed quote: Oct 6, 2026, 3:02 PM EDT
Total return — SNGX vs SNOA
growth of $100 · dividends reinvested · last 10ySNGX -100.0% (-57.6%/yr)SNOA -99.8% (-47.6%/yr)SNOA compounded faster over this window
Log scale — wide-divergence pair
SNGX SNOA
SNGX vs SNOA: by the numbers
- •SNOA is the larger company ($6M vs $5M market cap).
- •Both run net losses; SNGX's is the smaller (0.00% vs -10.33% net margin).
Metrics side by side
Valuation
| Metric | SNGX | SNOA |
|---|---|---|
| P/S ratio | N/A | 0.26 |
| P/B ratio | 0.80 | 0.88 |
Profitability
| Metric | SNGX | SNOA |
|---|---|---|
| Gross margin | 0.00% | 38.91% |
| Operating margin | 0.00% | -6.41% |
| Net margin | 0.00% | -10.33% |
| ROE | -154.08% | -34.33% |
| ROIC | -161.69% | -10.98% |
Growth (annualized)
| Metric | SNGX | SNOA |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 5.79% |
| Total return CAGR (5Y) | -72.72% | -59.29% |
Frequently asked
- How have SNGX and SNOA total returns compared?
- Over the past 10 years, SNGX delivered -57.62% and SNOA delivered -47.31% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.